Trade Alzamend Neuro, Inc. - ALZN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0204 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.1348 |
| Open | 1.1748 |
| 1-Year Change | 32.88% |
| Day's Range | 1.1448 - 1.1748 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 1.1748 | 0.0000 | 0.00% | 1.1748 | 1.1848 | 1.1448 |
| Jan 17, 2025 | 1.1448 | 0.0000 | 0.00% | 1.1448 | 1.1448 | 1.1248 |
| Jan 16, 2025 | 1.1348 | -0.0200 | -1.73% | 1.1548 | 1.1548 | 1.1148 |
| Jan 15, 2025 | 1.1548 | 0.0100 | 0.87% | 1.1448 | 1.1648 | 1.1248 |
| Jan 14, 2025 | 1.1148 | -0.0300 | -2.62% | 1.1448 | 1.1448 | 1.0948 |
| Jan 13, 2025 | 1.1348 | 0.0400 | 3.65% | 1.0948 | 1.1448 | 1.0748 |
| Jan 10, 2025 | 1.1048 | -0.0300 | -2.64% | 1.1348 | 1.1348 | 1.0848 |
| Jan 8, 2025 | 1.1348 | -0.0800 | -6.59% | 1.2148 | 1.2148 | 1.1348 |
| Jan 7, 2025 | 1.2348 | -0.0300 | -2.37% | 1.2648 | 1.2748 | 1.1748 |
| Jan 6, 2025 | 1.2548 | -0.0200 | -1.57% | 1.2748 | 1.2748 | 1.1948 |
| Jan 3, 2025 | 1.2448 | 0.0600 | 5.06% | 1.1848 | 1.2448 | 1.1848 |
| Jan 2, 2025 | 1.1948 | 0.0300 | 2.58% | 1.1648 | 1.2048 | 1.1448 |
| Dec 31, 2024 | 1.1448 | -0.0800 | -6.53% | 1.2248 | 1.2248 | 1.1248 |
| Dec 30, 2024 | 1.1948 | 0.0100 | 0.84% | 1.1848 | 1.2148 | 1.1348 |
| Dec 27, 2024 | 1.1948 | -0.0300 | -2.45% | 1.2248 | 1.2248 | 1.1348 |
| Dec 26, 2024 | 1.2248 | 0.0400 | 3.38% | 1.1848 | 1.2348 | 1.1648 |
| Dec 24, 2024 | 1.1748 | 0.0100 | 0.86% | 1.1648 | 1.1748 | 1.1348 |
| Dec 23, 2024 | 1.1248 | -0.0300 | -2.60% | 1.1548 | 1.1548 | 1.1248 |
| Dec 20, 2024 | 1.1248 | -0.0600 | -5.06% | 1.1848 | 1.1948 | 1.1248 |
| Dec 19, 2024 | 1.2348 | 0.0100 | 0.82% | 1.2248 | 1.2748 | 1.1748 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Alzamend Neuro, Inc. Company profile
About Alzamend Neuro Inc
Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company focused on developing products for the treatment of neurodegenerative diseases and psychiatric disorders. The Company's pipeline consists of two therapeutic drug candidates: AL001 and AL002. The AL001 is a cocrystal technology delivering a therapeutic combination of lithium, proline and salicylate, known as AL001 or LiProSal, through two royalty-bearing worldwide licenses from the University of South Florida Research Foundation, Inc. (licensor). AL002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s, known as AL002 or CA022W, through a royalty-bearing worldwide license from the licensor.
Financial summary
BRIEF: For the nine months ended 31 January 2022, Alzamend Neuro Inc revenues was not reported. Net loss increased from $3.8M to $8.5M. Higher net loss reflects Research and development - Bal increase from $953K to $3.2M (expense), Stock-based Compensation in SGA increase of 67% to $2.8M (expense), General and administrative - Bal increase from $547K to $1.1M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
3480 Peachtree Road NE,
Second Floor, Suite 103
ATLANTA
GEORGIA 30326
US
News
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com